2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one
C23H26N8O3 — CID 163215456
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one
2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one (PubChem CID 163215456) has the molecular formula C23H26N8O3 and a molecular weight of 462.51 g/mol. Its IUPAC name is 2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one.
Molecular Properties
| Compound Name | 2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one |
|---|---|
| PubChem CID | 163215456 |
| Molecular Formula | C23H26N8O3 |
| Molecular Weight | 462.51 g/mol |
| Exact Mass | 462.21 |
| IUPAC Name | 2-amino-8-[2-[4-(5-methoxy-2-pyridinyl)piperazin-1-yl]ethyl]-4-(5-methylfuran-2-yl)pteridin-7-one |
| SMILES | COc1ccc(N2CCN(CCn3c(=O)cnc4c(-c5ccc(C)o5)nc(N)nc43)CC2)nc1 |
| InChI | InChI=1S/C23H26N8O3/c1-15-3-5-17(34-15)20-21-22(28-23(24)27-20)31(19(32)14-26-21)12-9-29-7-10-30(11-8-29)18-6-4-16(33-2)13-25-18/h3-6,13-14H,7-12H2,1-2H3,(H2,24,27,28) |
| InChIKey | INHFBANAGPCJPP-UHFFFAOYSA-N |
| XLogP | 1.56 |
| TPSA | 128.43 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.51 |
| LogP ≤ 5 | 1.56 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163215456 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.